Wedmont Private Capital’s Zimmer Biomet ZBH Stock Holding History

Wedmont Private Capital’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,812	Closed	-$258K	–	538
2023 Q2	$258K	Sell	1,812 -7	-0.4%	-$951	0.03%	419
2023 Q1	$233K	Buy	1,819 +197	+12%	+$24.7K	0.03%	407
2022 Q4	$204K	Buy	+1,622	New	+$188K	0.03%	427
2022 Q3	–	Sell	-2,110	Closed	-$222K	–	409
2022 Q2	$222K	Sell	2,110 -211	-9%	-$25K	0.05%	299
2022 Q1	$292K	Buy	+2,321	New	+$280K	0.07%	243

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wedmont Private Capital's ZBH Position: Q3 2023 in Review

Wedmont Private Capital sold out of Zimmer Biomet (ZBH) in Q3 2023, closing a stake of 1,812 shares — an estimated $258K sold.

Wedmont Private Capital first reported a position in ZBH in Q1 2022 and held it in 5 quarters. The position peaked at $292K in Q1 2022. 1,016 funds tracked by Wall St. Rank hold ZBH as of Q3 2023.

Wedmont Private Capital reported no remaining Zimmer Biomet position as of Q3 2023 after selling out during the quarter.
Wedmont Private Capital sold 1,812 Zimmer Biomet shares in Q3 2023, an estimated $258K.
Wedmont Private Capital first reported a position in Zimmer Biomet in Q1 2022 and held it in 5 quarters.
Wedmont Private Capital's Zimmer Biomet position peaked at $292K in Q1 2022.
1,016 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2023.

Based on Wedmont Private Capital's 13F filing for Q3 2023, filed 10 Oct 2023.